e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
December 9, 2010 (December 9, 2010)
Date of Report (date of earliest event reported)
COMMUNITY HEALTH SYSTEMS, INC.
(Exact name of Registrant as specified in charter)
|
|
|
|
|
Delaware
|
|
001-15925
|
|
13-3893191 |
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.) |
4000 Meridian Boulevard
Franklin, Tennessee 37067
(Address of principal executive offices)
Registrants telephone number, including area code: (615) 465-7000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
þ Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (l7 CFR 240.13e-4(c))
Item 8.01. Other Events.
On December 9, 2010, Community Health Systems, Inc. (the Company) issued a press release
announcing that it has submitted a proposal to the Board of Directors of Tenet Healthcare
Corporation (Tenet) to acquire all of the outstanding shares of Tenet for $6.00 per share in cash
and stock of the Company. The press release, including the full text of a letter dated December 9,
2010 to the Board of Directors of Tenet communicating the Companys proposal, is attached hereto as
Exhibit 99.1 and incorporated by reference into this Item 8.01.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit No. |
|
Description |
|
|
|
99.1
|
|
Press release issued by Community Health Systems, Inc., dated
December 9, 2010. |
|
|
|
99.2
|
|
Investor Presentation Materials, dated December 9, 2010. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
Date: December 9, 2010 |
COMMUNITY HEALTH SYSTEMS, INC.
(Registrant)
|
|
|
By: |
/s/ Wayne T. Smith
|
|
|
|
Wayne T. Smith |
|
|
|
Chairman of the Board,
President and Chief Executive Officer
(principal executive officer) |
|
|
|
|
|
|
By: |
/s/ W. Larry Cash
|
|
|
|
W. Larry Cash |
|
|
|
Executive Vice President, Chief Financial
Officer and Director
(principal financial officer) |
|
EXHIBIT INDEX
|
|
|
Exhibit No. |
|
Description |
|
|
|
99.1
|
|
Press release issued by Community Health Systems, Inc.,
dated December 9, 2010. |
|
|
|
99.2
|
|
Investor Presentation Materials, dated December 9, 2010. |
exv99w1
Exhibit 99.1
COMMUNITY HEALTH SYSTEMS OFFERS TO ACQUIRE TENET HEALTHCARE
FOR $6.00 PER SHARE IN CASH AND STOCK
Combination Would Create Nations Largest Hospital Chain
$7.3
Billion Transaction Would Provide 40% Premium to Tenet Shareholders
FRANKLIN, Tenn., December 9, 2010 Community Health Systems, Inc. (NYSE: CYH) (CHS) today
announced that it has made an offer to acquire Tenet Healthcare Corporation (NYSE: THC) for $6.00
per share, including $5.00 per share in cash and $1.00 per share in CHS common stock, which
represents a premium of 40% over Tenets closing stock price today. In addition to receiving a
substantial cash premium, Tenet shareholders would share in the upside of the combined company
through the stock portion of the consideration.
The total value of the transaction would be approximately $7.3 billion, including $3.3 billion of
equity and approximately $4 billion of net debt. The offer was made in a letter to Tenets Board
of Directors on November 12, 2010, and rejected by Tenet on December 6, 2010. CHS today sent
another letter to the Tenet Board (see below).
The combination of CHS and Tenet would be both financially and strategically compelling. The
combined company would have approximately $22 billion in pro forma annual revenue and own or
operate 176 hospitals in 30 states with a total of 32,830 licensed beds. The acquisition
of Tenet is expected to be accretive to CHSs earnings per share in the first full year after
closing, excluding one-time costs.
CHS has a reputation for superior operating performance and a successful track record of
integrating acquisitions. CHS believes the complementary fit of the two companies, the geographic
proximity of their facilities, and the ability to enhance the operating efficiencies and best
practices of a combined organization would enable it to provide even higher quality care for
patients and broader and more effective services to the communities it serves.
CHSs financial advisor is Credit Suisse and its legal advisor is Kirkland & Ellis LLP.
CHS will hold a conference call to discuss this press release on Friday, December 10, 2010, at 9:30
a.m. Central, 10:30 a.m. Eastern time. Investors will have the opportunity to listen to a live
internet broadcast of the conference call by clicking on the Investor Relations link of the
Companys website at www.chs.net, or at www.earnings.com. To listen to the live call, please go to
the website at least fifteen minutes early to register, download and install any necessary audio
software. For those who cannot listen to the live broadcast, a replay will be available after the
call and will continue through January 10, 2011.
Below is the full text of the letter sent today by CHS to Tenet:
December 9, 2010
Board of Directors
Tenet Healthcare Corporation
1445 Ross Avenue
Dallas, Texas 75202
Attention: |
|
Mr. Trevor Fetter
President and Chief Executive Officer |
Ladies and Gentlemen:
We were surprised and disappointed by your flat rejection of a transaction that would
provide a premium of approximately 40% to Tenet Healthcare Corporation shareholders. As you
know, Community Health Systems, Inc. (CHS) has offered to acquire all of the outstanding shares of Tenet at a price of $6.00 per share ($5.00 in cash and $1.00 in CHS stock). We
are convinced this transaction would be very attractive to Tenet shareholders and we do
not understand how you could state in your letter of December 6 that our proposal does not
offer even remotely fair value to Tenet shareholders.
Given your position, we have concluded it is now appropriate to publicly disclose our
proposal. This will allow Tenet shareholders to decide for themselves if they prefer the
substantial premium and high degree of certainty offered in this transaction or would
rather continue to accept the significant risk, especially in light of recent operating
performance, that Tenet can achieve greater present value for shareholders through execution
of its strategic plan in the years ahead.
The combination of CHS and Tenet is both financially and strategically compelling. At $6.00
per share, our proposal provides a 40% premium over Tenets closing stock price today which
is materially higher than the average premium paid in similar size transactions over the
last five years. In addition to receiving a substantial cash premium, Tenet shareholders
will share in the upside of the combination through the stock portion of the consideration,
which will be based on a fixed exchange ratio. The total value of the transaction would be
approximately $7.3 billion.
CHS is the nations largest publicly traded hospital company and a leading operator of
general acute care hospitals in non-urban and mid-size markets across the country, with a
reputation for superior operating performance and a successful track record of acquisitions.
The complementary fit of our two companies, the geographic proximity of
our facilities, and the ability to enhance the operating efficiencies and best practices of
a combined organization would enable us to provide even higher quality care for our patients
and broader and more effective services to the communities we serve. For physicians, the
breadth and strength of the combined company would offer attractive practice opportunities.
With expanded scale and market reach, the combined company would also be well positioned to
effectively navigate healthcare reform.
The combined company would have approximately $22 billion in annual revenue and own or
operate 176 hospitals in 30 states with a total of 32,830 licensed beds. The combined
companys facilities would be diversified across urban and non-urban markets.
CHS has an extremely successful acquisition and integration track record, most notably
evidenced by our acquisition of Triad Hospitals in 2007, and has demonstrated expertise in
achieving large-scale transactional and operational synergies. We expect this acquisition
to be accretive to our earnings per share in the first full year, excluding one-time costs.
It remains our strong desire to reach an agreement with Tenet. However, we are committed to
completing this transaction and will consider all alternatives necessary to do so. Our
proposal is based on our analysis of publicly available information. As we have made clear
to your advisors, we would welcome the opportunity to review any additional information you
provide and are prepared to recognize any additional value you can demonstrate.
We do not believe there are any financial or regulatory impediments to your shareholders
timely realization of this substantial premium. The cash portion of the consideration would
be financed with available cash on hand together with external debt financing. We have
analyzed this combination in detail with our financial advisors at Credit Suisse and are
highly confident that we can deliver a fully financed transaction. Prior to the execution
of the definitive transaction agreements, we anticipate receiving financing commitments in
an amount sufficient to fund the transaction. We have conducted a preliminary antitrust
review and do not believe the combination would give rise to any significant antitrust
issues. In addition, we do not expect the transaction would require approval by CHS
shareholders.
This transaction is a strategic priority for us and has the full attention of our management
team and the unanimous support of our Board of Directors. Accordingly, we and our financial
and legal advisors at Credit Suisse and Kirkland & Ellis LLP are prepared to devote the
resources necessary to complete our due diligence activities and
negotiate and execute mutually acceptable definitive documentation in an expedited manner.
I want to reiterate CHSs commitment to successfully completing this compelling transaction.
By refusing to negotiate with us, you are delaying your shareholders ability to receive
the substantial financial and strategic benefits of this transaction. We stand ready to
meet with you and your advisors to move this transaction forward without further delay.
Sincerely,
|
|
|
|
|
|
|
|
/s/ Wayne T. Smith
|
|
|
Wayne T. Smith |
|
|
Chairman of the Board,
President and Chief Executive Officer |
|
|
About Community Health Systems, Inc.
Located in the Nashville, Tennessee, suburb of Franklin, Community Health Systems, Inc. is the
largest publicly traded hospital company in the United States and a leading operator of general
acute care hospitals in non-urban and mid-size markets throughout the country. Through its
subsidiaries, the Company currently owns, leases or operates 126 hospitals in 29 states with an
aggregate of approximately 19,400 licensed beds. Its hospitals offer a broad range of inpatient and
surgical services, outpatient treatment and skilled nursing care. In addition, through its
subsidiary Quorum Health Resources, LLC, the Company provides management and consulting services to
approximately 150 independent non-affiliated general acute care hospitals located throughout the
United States.
Forward-Looking Statements
Any statements made in this news release that are not statements of historical fact, including
statements about our beliefs and expectations, including any benefits of the proposed acquisition
of Tenet Healthcare Corporation (Tenet), are forward-looking statements within the meaning of the
federal securities laws and should be evaluated as such. Forward-looking statements include
statements that may relate to our plans, objectives, strategies, goals, future events, future
revenues or performance, and other information that is not historical information. These
forward-looking statements may be identified by words such as anticipate, expect, suggest,
plan, believe, intend, estimate, target, project, could, should, may, will,
would, continue, forecast, and other similar expressions.
These forward-looking statements involve risks and uncertainties, and you should be aware that many
factors could cause actual results or events to differ materially from those expressed in the
forward-looking statements. Factors that may materially affect such forward-looking statements
include: our ability to successfully complete any proposed transaction or realize the anticipated
benefits of a transaction, our ability to obtain stockholder, antitrust, regulatory and other
approvals for any proposed transaction, or an inability to obtain them on the terms proposed or on
the anticipated schedule, and uncertainty of our expected financial performance following
completion of any proposed transaction. Forward-looking statements, like all statements in this
news release, speak only as of the date of this news release (unless another date is indicated). We
do not undertake any obligation to publicly update any forward-looking statements, whether as a
result of new information, future events, or otherwise.
Additional Information
This communication does not constitute an offer to sell or the solicitation of an offer to buy any
securities or a solicitation of any vote or approval. This news release relates to a business
combination transaction with Tenet proposed by the Company, which may become the subject of a
registration statement filed with the Securities and Exchange Commission (the SEC). This
material is not a substitute for any prospectus, proxy statement or any other document which the
Company may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY
HOLDERS ARE URGED TO READ ANY SUCH DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY IF AND
WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT
THE PROPOSED TRANSACTION. Such documents would be available free of charge through the web site maintained by
the SEC at www.sec.gov or by directing a request to Community Health Systems, Inc. at 4000
Meridian Boulevard, Franklin, TN 37067, Attn: Investor Relations.
The Company and its directors and executive officers and other persons may be deemed to be
participants in any solicitation of proxies from Tenets stockholders in respect of the proposed
transaction with Tenet. Information regarding the Companys directors and executive officers is
available in its proxy statement for its 2010 annual meeting of stockholders, which was filed with
the SEC on April 9, 2010. Other information regarding potential participants in such proxy
solicitation and a description of their direct and indirect interests, by security holdings or
otherwise, will be contained in any proxy statement filed in connection with the proposed
transaction.
|
|
|
Media Contacts:
|
|
Investor Contacts: |
|
|
|
Tomi Galin
|
|
W. Larry Cash |
VP Corporate Communications
|
|
EVP & CFO |
615-628-6607
|
|
615-465-7000 |
|
|
|
George Sard/Anna Cordasco/Brooke Gordon
|
|
Lizbeth Schuler |
Sard Verbinnen & Co
|
|
VP Investor Relations |
212-687-8080
|
|
615-465-7000 |
exv99w2
Exhibit
99.2
Community Health Systems and Tenet Healthcare:
A Compelling Opportunity for Value Creation
December 9, 2010
|
Any statements made in this presentation that are not statements of historical fact, including statements
about our beliefs and expectations, including any benefits of the proposed acquisition of Tenet Healthcare
Corporation ("Tenet"), are forward-looking statements within the meaning of the federal securities laws and
should be evaluated as such. Forward-looking statements include statements that may relate to our plans,
objectives, strategies, goals, future events, future revenues or performance, and other information that is not
historical information. These forward-looking statements may be identified by words such as "anticipate,"
"expect," "suggest," "plan," believe," "intend," "estimate," "target," "project," "could," "should," "may," "will,"
"would," "continue," "forecast," and other similar expressions. These forward-looking statements involve
risks and uncertainties, and you should be aware that many factors could cause actual results or events to
differ materially from those expressed in the forward-looking statements. Factors that may materially affect
such forward-looking statements include: our ability to successfully complete any proposed transaction or
realize the anticipated benefits of a transaction, our ability to obtain stockholder, antitrust, regulatory and
other approvals for any proposed transaction, or an inability to obtain them on the terms proposed or on the
anticipated schedule, and uncertainty of our expected financial performance following completion of any
proposed transaction. Forward-looking statements, like all statements in this presentation, speak only as of
the date of this presentation (unless another date is indicated). We do not undertake any obligation to
publicly update any forward-looking statements, whether as a result of new information, future events, or
otherwise.
Forward-Looking Statements
|
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or
a solicitation of any vote or approval. This presentation relates to a business combination transaction with
Tenet proposed by Community Health Systems, Inc. ("CHS" or "the Company"), which may become the
subject of a registration statement filed with the Securities and Exchange Commission (the "SEC"). This
material is not a substitute for any prospectus, proxy statement or any other document which the Company
may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY
HOLDERS ARE URGED TO READ ANY SUCH DOCUMENTS FILED WITH THE SEC CAREFULLY IN
THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN
IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Such documents would be
available free of charge through the web site maintained by the SEC at www.sec.gov or by directing a
request to Community Health Systems, Inc. at 4000 Meridian Boulevard, Franklin, TN 37067, Attn: Investor
Relations.
The Company and its directors and executive officers and other persons may be deemed to be participants
in any solicitation of proxies from Tenet's stockholders in respect of the proposed transaction with Tenet.
Information regarding the Company's directors and executive officers is available in its proxy statement for
its 2010 annual meeting of stockholders, which was filed with the SEC on April 9, 2010. Other information
regarding potential participants in such proxy solicitation and a description of their direct and indirect
interests, by security holdings or otherwise, will be contained in any proxy statement filed in connection with
the proposed transaction.
Additional Information
|
Compelling Strategic Rationale
Strong complementary fit with significant synergy potential
Opportunity to leverage operating efficiencies and best practices
Enhances ability to contract effectively with payors
More attractive platform for physician recruitment
CHS management team has proven track record of superior
operating performance
Successfully integrated Triad acquisition - a transaction that was
larger on a relative basis
Transaction is accretive to EPS in the first full year
|
$6.00 offer price per share comprised of $5.00 in cash and $1.00 in CHS stock
Offer represents 40% premium to December 9, 2010 closing price for Tenet
Stock consideration provides Tenet shareholders the opportunity to participate
in future upside from earnings growth and synergy realization
Credit Suisse has provided to us a letter indicating that it is highly confident it
can arrange the debt financing for the transaction along with a syndicate of
other financial institutions (1)
Strong desire to reach an agreement with Tenet on a friendly basis, but
committed to completing this transaction
(1) Subject to customary terms and conditions.
Attractive Offer for Tenet Shareholders
|
Combined Company
Pro Forma
Tenet
Note: Revenue as of LTM 9/30/10.
Revenue
$12.7 billion
$9.2 billion
$21.9 billion
Hospitals
126
50
176
States
29
11
30
Licensed Beds
19,400
13,430
32,830
|
Transaction Benefits Key Constituents
Improved quality of care from standardized best
practices and clinical protocols
Breadth of platform and stable operations
provide attractive practice opportunities
Comprehensive range of healthcare services
provided in cost-efficient manner
Enhances ability to provide broader and more
effective services
Patients
Physicians
Payors /
Employers
Communities
|
Favorable Geographic Fit
Geographic overlap - only new state is Nebraska
CHS in 29 states; Tenet in 11 states; pro forma combined in 30 states
Diversified across urban and non-urban markets
Potential referral synergies
Well positioned with managed care organizations and for future impact of healthcare reform
Legend
CHS presence only
Tenet presence only
CHS and Tenet overlap
CHS
Tenet
|
CHS / Tenet Combined
Increased purchasing power
Leverage operating efficiencies
Best practices across portfolio
Hospital Company Comparison
HCA
CHS
HMA
Tenet
LifePoint
UHS
Combined Company Has a
Scale Advantage
Note: Revenue as of LTM 9/30/10.
|
CHS Management Team Has a Proven
Track Record of Superior Operating Performance
5.4%
4.1%
9.1%
5.9%
Tenet
$3,031mm
$930mm
Superior
Organic Growth
Average Annual Same-Facility
Revenue Growth
2008 - 2010 YTD
Average EBITDA* Margin
2008 - 2010 YTD
Average EBIT Margin
2008 - 2010 YTD
Cumulative Cash Flow From
Operations
2008 - 2010 YTD
Cumulative Cash Flow From
Operations as % of Revenue
2008 - 2010 YTD
13.8%
10.2%
9.3%
3.8%
Better,
Consistent
Profitability
Stronger
Cash Flow
* For CHS, see the Unaudited Supplemental Information contained in this presentation for a definition of EBITDA and a reconciliation of Adjusted
EBITDA, as defined, to CHS' net cash provided by operating activities as derived directly from our consolidated financial statements for the twelve
months ended December 31, 2009 and 2008. For purposes of this presentation, EBITDA means Adjusted EBITDA.
Management
Expertise
#1 Institutional Investor
Ranking
CEO and CFO
4 years in a row
Note: Figures represent financial performance during calendar year 2008, calendar year 2009 and nine months ended September 30, 2010.
|
Target Contribution to Combined Company
Tenet Acquisition Relative to Triad
Triad
Tenet
Revenue
56%
42%
EBITDA
55%
36%
Beds
51%
41%
Hospitals
41%
28%
LTM as of 12/31/06
LTM as of 9/30/10
CHS has successfully integrated Triad.
On a relative basis, Tenet is a smaller acquisition.
|
Triad Facilities
LTM 6/30/07 0.12
CY 2009 0.148
+280 bps
CHS Management Significantly Improved
Triad's Operating Results
Pre-acquisition
Margin Improvement
Substantial corporate cost savings and
purchasing synergies achieved
First Calendar Year: $145 million
Peak Synergies: Over $275 million
Recruited ~2,400 physicians to Triad
facilities since acquisition
Focused CapEx on high ROI projects
|
Deep and Experienced Management Team
Wayne T. Smith Chairman, President and CEO 30+ President and Chief Operating Officer at
Humana
W. Larry Cash Executive Vice President and CFO 30+ Vice President and Group CFO at HCA; Senior
Vice President of Finance & Operations at
Humana
William S. Hussey President, Division IV 25 Joined as AVP in 2001; Divisional President -
Tampa Bay Division, HCA
David L. Miller President, Division I 30+ Divisional Vice President - HMA;
Various CEO positions with Humana
Thomas D. Miller President, Division V 20 President & CEO - Lutheran Health;
CEO of Tri Cities Market - HCA
Michael T. Portacci President, Division II 25 Joined as Hospital CEO in 1987;
Became Group VP in 1991
Martin D. Smith President, Division III 15 Joined as Hospital CEO in 1998 and became
Division III VP of Operations in 2005;
Various positions with HMA
Name
Title
Background
Experience
|
CHS Has Delivered Consistent
Results For Years
1996 108
1997 122
1998 166
1999 203
2000 251
2001 291
2002 349
2003 429
2004 494
2005 573
2006 572
2007 827
2008 1513
2009 1671
($MM)
1996 622
1997 742
1998 855
1999 1052
2000 1306
2001 1531
2002 2039
2003 2677
2004 3204
2005 3738
2006 4180
2007 7127
2008 10919
2009 12107.6
26% CAGR
23% CAGR
Revenues
EBITDA *
($MM)
* For CHS, see the Unaudited Supplemental Information contained in this presentation for a definition of EBITDA and a reconciliation of Adjusted EBITDA, as
defined, to CHS' net cash provided by operating activities as derived directly from our consolidated financial statements for the twelve months ended December
31, 2009 and 2008. For purposes of this presentation, EBITDA means Adjusted EBITDA.
2007 amounts include adjustments for change in estimate taken in Q407.
2006 EBITDA includes increase in allowance for doubtful accounts of $65 million taken in Q306.
|
Summary
Strong complementary fit with significant synergy potential
Offer represents 40% premium to December 9, 2010 closing
price for Tenet
Stock consideration provides Tenet shareholders the opportunity
to participate in future upside from earnings growth and synergy
realization
CHS management team has proven track record of superior
operating performance
Transaction is accretive to EPS in the first full year
Strong desire to reach an agreement with Tenet on a friendly
basis, but committed to completing this transaction
|
Unaudited Supplemental Information
EBITDA consists of net income attributable to Community Health Systems, Inc. before interest,
income taxes, and depreciation and amortization. Adjusted EBITDA is EBITDA adjusted to
exclude discontinued operations, gain/loss from early extinguishment of debt and net income
attributable to noncontrolling interests. The Company has from time to time sold
noncontrolling interests in certain of its subsidiaries or acquired subsidiaries with existing
noncontrolling interest ownership positions. The Company believes that it is useful to present
adjusted EBITDA because it excludes the portion of EBITDA attributable to these third party
interests and clarifies for investors the Company's portion of EBITDA generated by continuing
operations. The Company uses adjusted EBITDA as a measure of liquidity. The Company has
included this measure because it believes it provides investors with additional information
about the Company's ability to incur and service debt and make capital expenditures.
Adjusted EBITDA is the basis for a key component in the determination of the Company's
compliance with some of the covenants under the Company's senior secured credit facility, as
well as to determine the interest rate and commitment fee payable under the senior secured
credit facility.
Adjusted EBITDA is not a measurement of financial performance or liquidity under generally
accepted accounting principles. It should not be considered in isolation or as a substitute for
net income, operating income, cash flows from operating, investing or financing activities, or
any other measure calculated in accordance with generally accepted accounting principles.
The items excluded from adjusted EBITDA are significant components in understanding and
evaluating financial performance and liquidity. This calculation of adjusted EBITDA may not
be comparable to similarly titled measures reported by other companies.
|
Unaudited Supplemental Information Continued
The following table reconciles ADJUSTED EBITDA, as defined, to our net cash provided by operating
activities as derived directly from the condensed consolidated financial statements for the years ended
December 31, 2009 and 2008 (in thousands):
|